1887

Journal of Medical Microbiology logo

Volume 65, Issue 9

Discrepancy between genotypic and phenotypic extended-spectrum -lactamase rates in from intra-abdominal infections in the USA Free

Abstract

Varying rates of false-positive results of phenotypic extended-spectrum β-lactamase (ESBL) tests have been reported for different methods in different settings, species and geographic locations. This report describes discrepancies in genotypic and phenotypic ESBL rates observed in a surveillance study of 29 US hospitals that participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART). The ESBL phenotype was determined with the Clinical and Laboratory Standards Institute confirmatory broth microdilution test using cefotaxime and ceftazidime with and without clavulanate. Genes encoding ESBLs, carbapenemases and plasmidic AmpC β-lactamases were detected using a combination of microarray and multiplex PCR assays. Among 168 molecularly characterized phenotypically ESBL-positive isolates from intra-abdominal infections, 4.8 % were genotypically negative from 2009 to 2012 and 29.5 % in 2013. Because of the high rate of false-positive phenotypic ESBL results in 2013, the 5-year phenotypic ESBL trend was skewed and showed a statistically significant increase (<0.05) in ESBL-positive in the USA, which was not seen using the genotypic ESBL rates. The majority of false-positive phenotypic profiles had ceftazidime MICs of 2 µg ml and a ≥3 doubling dilution decrease in MIC for only one of the two antimicrobial agents. False-positive ESBL results can adversely impact epidemiological surveillance and patient care (including inappropriate treatment, unnecessary patient isolation and higher costs). Careful evaluation and comparison of phenotypic and genotypic test results can yield the greatest insight, but the most accurate (and faster) detection of ESBL producers is usually based on molecular data.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): ESBL , Escherichia coli , genotype , phenotype and SMART
© 2016 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000307
2016-09-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/9/905.html?itemId=/content/journal/jmm/10.1099/jmm.0.000307&mimeType=html&fmt=ahah

References

  1. Beceiro A., Maharjan S., Gaulton T., Doumith M., Soares N. C., Dhanji H., Warner M., Doyle M., Hickey M. et al. 2011; False extended-spectrum β-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins. J Antimicrob Chemother 66:2006–2010 [View Article][PubMed]
     [Google Scholar]
  2. CLSI 2015a Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Approved Standards , 9th edn. CLSI documents M07-A10 Wayne, PA: Clinical and Laboratory Standards Institute;
     [Google Scholar]
  3. CLSI 2015b Performance Standards for Antimicrobial Susceptibility Testing Twenty-Fifth Informational Supplement CLSI Document M100-S25 Wayne, PA: Clinical and Laboratory Standards Institute;
     [Google Scholar]
  4. Dhillon R. H.-P., Clark J. 2012; ESBLs: a clear and present danger?. Crit Care Res Pract 2012:1–11 Article ID 625170. http://www.hindawi.com/journals/ccrp/2012/ [View Article]
     [Google Scholar]
  5. Endimiani A., Paterson D. L. 2007; Optimizing therapy for infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases. Semin Respir Crit Care Med 28:646–655 [View Article][PubMed]
     [Google Scholar]
  6. Garrec H., Drieux-Rouzet L., Golmard J. L., Jarlier V., Robert J. 2011; Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae . J Clin Microbiol 49:1048–1057 [CrossRef]
     [Google Scholar]
  7. Gazin M., Paasch F., Goossens H., Malhotra-Kumar S. MOSAR WP2 and SATURN WP1 Study Teams 2012; Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae . J Clin Microbiol 50:1140–1146 [View Article][PubMed]
     [Google Scholar]
  8. Hoban D. J., Lascols C., Nicolle L. E., Badal R., Bouchillon S., Hackel M., Hawser S. 2012; Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009–2010. Diagn Microbiol Infect Dis 74:62–67 [View Article][PubMed]
     [Google Scholar]
  9. Kavi J., Bhattacharjee D., Macve J., Weinbren M. J. 2013; Comment on: Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?. J Antimicrob Chemother 68:246 [View Article][PubMed]
     [Google Scholar]
  10. Kazmierczak K. M., Lob S. H., Hoban D. J., Hackel M. A., Badal R. E., Bouchillon S. K. 2015; Characterization of extended-spectrum beta-lactamases and antimicrobial resistance of Klebsiella pneumoniae in intra-abdominal infection isolates in Latin America, 2008–2012. Results of the Study for Monitoring Antimicrobial Resistance Trends. Diagn Microbiol Infect Dis 82:209–214 [View Article][PubMed]
     [Google Scholar]
  11. Livermore D. M., Andrews J. M., Hawkey P. M., Ho P. L., Keness Y., Doi Y., Paterson D., Woodford N. 2012; Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?. J Antimicrob Chemother 67:1569–1577 [View Article][PubMed]
     [Google Scholar]
  12. Lob S. H., Kazmierczak K. M., Badal R. E., Hackel M. A., Bouchillon S. K., Biedenbach D. J., Sahm D. F. 2015; Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013. Antimicrob Agents Chemother 59:3606–3610 [View Article][PubMed]
     [Google Scholar]
  13. Lupo A., Papp-Wallace K. M., Sendi P., Bonomo R. A., Endimiani A. 2013; Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae . Diagn Microbiol Infect Dis 77:179–194 [View Article][PubMed]
     [Google Scholar]
  14. Morrissey I., Bouchillon S. K., Hackel M., Biedenbach D. J., Hawser S., Hoban D., Badal R. E. 2014; Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates. J Med Microbiol 63:556–561 [View Article][PubMed]
     [Google Scholar]
  15. Paterson D. L., Bonomo R. A. 2005; Extended-spectrum beta- lactamases: a clinical update. Clin Microbiol Rev 18:657–686 [View Article][PubMed]
     [Google Scholar]
  16. Platteel T. N., Cohen Stuart J. W., de Neeling A. J., Voets G. M., Scharringa J., van de Sande N., Fluit A. C., Bonten M. J., Leverstein-van Hall M. A. ESBL national surveillance working group 2013; Multi-centre evaluation of a phenotypic extended spectrum β-lactamase detection guideline in the routine setting. Clin Microbiol Infect 19:70–76 [View Article][PubMed]
     [Google Scholar]
  17. Solomkin J. S., Mazuski J. E., Bradley J. S., Rodvold K. A., Goldstein E. J., Baron E. J., O'Neill P. J., Chow A. W., Dellinger E. P. et al. 2010; Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect 11:79–109 [View Article][PubMed]
     [Google Scholar]
  18. Tofteland S., Haldorsen B., Dahl K. H., Simonsen G. S., Steinbakk M., Walsh T. R., Sundsfjord A. Norwegian ESBL Study Group 2007; Effects of phenotype and genotype on methods for detection of extended-spectrum-β-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol 45:199–205 [View Article][PubMed]
     [Google Scholar]
  19. Waltner-Toews R. I., Paterson D. L., Qureshi Z. A., Sidjabat H. E., Adams-Haduch J. M., Shutt K. A., Jones M., Tian G. B., Pasculle A. W., Doi Y. 2011; Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction. Antimicrob Agents Chemother 55:495–501 [View Article][PubMed]
     [Google Scholar]
  20. Wintermans B. B., Reuland E. A., Wintermans R. G., Bergmans A. M., Kluytmans J. A. 2013; The cost-effectiveness of ESBL detection: towards molecular detection methods?. Clin Microbiol Infect 19:662–665 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000307
Loading
Discrepancy between genotypic and phenotypic extended-spectrum β-lactamase rates in Escherichia coli from intra-abdominal infections in the USA
J. Med. Microbiol. 65, 905 (2016); https://doi.org/10.1099/jmm.0.000307
/content/journal/jmm/10.1099/jmm.0.000307
/content/journal/jmm/10.1099/jmm.0.000307
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error